Baird Robert, Salasidis Robert
Department of General Surgery, McGill University Health Center, Montreal, Canada.
Gastrointest Endosc. 2004 Apr;59(4):570-4. doi: 10.1016/s0016-5107(04)00004-5.
There are few data on the safety of PEG in patients with a ventriculoperitoneal shunt.
Medical records for patients seen in 3 tertiary care, university-affiliated hospitals between January 1, 1991, and January 1, 1999, were reviewed.
Six patients underwent PEG after ventriculoperitoneal shunt placement during the study period. There was no immediate complication. One patient died of pneumonia 2 months after PEG insertion. There was no instance of shunt malfunction, intra-abdominal complication, or wound infection in the study group. There was no long-term complication, with either the ventriculoperitoneal shunt or the PEG.
Although the number of cases was small, PEG placement with prophylactic administration of antibiotics appears to be safe in patients with a pre-existing ventriculoperitoneal shunt.
关于聚乙二醇（PEG）在脑室腹腔分流术患者中的安全性数据较少。
回顾了1991年1月1日至1999年1月1日期间在3家大学附属医院三级医疗中心就诊患者的病历。
在研究期间，6例患者在脑室腹腔分流术后接受了PEG治疗。无即刻并发症发生。1例患者在PEG置入后2个月死于肺炎。研究组未发生分流器故障、腹腔内并发症或伤口感染。脑室腹腔分流术或PEG均未出现长期并发症。
尽管病例数较少，但对于已有脑室腹腔分流术的患者，预防性使用抗生素进行PEG置入似乎是安全的。
